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A B S T R A C T
Microsporidia are often considered as an opportunistic infection in patients with impaired immune systems such
as transplant recipients and patients with acquired immune deﬁciency syndrome (AIDS). Due to the increasing
prevalence of parasitic infections and immunodeﬁciency diseases; the aim of the study is to evaluate molecular
identiﬁcation of Enterocytozoon bieneusi and Encephalitozoon spp. in immunodeﬁcient patients in Ahvaz,
southwest of Iran. At ﬁrst, 310 stool samples were collected from patients with immunodeﬁciency. The
specimens were stained by modiﬁed trichrome (weber) and were examined microscopically. The extracted DNA
samples were evaluated by multiplex/nested PCR method. The products of multiplex/nested PCR were explored
by RFLP method using the restriction enzyme of Mnl1. Of 310, 93 samples were suspected positive for
microsporidia by the staining. Also, of 310, 88 samples were positive by the multiplex/nested-PCR test that 62
samples were positive for E. bieneusi as well as 26 were detected as Encephalitozoon species that including 3 E.
cuniculi, 19 E. intestinalis and 4 E. hellem. Of 62 E. bieneusi, 45, 16 and 1 were detected as genotype D, M and
WL11, respectively. Also, Of 3 E. cuniculi, 1 and 2 cases were identiﬁed as genotype I and II, respectively. All E.
hellem samples were included genotype 1A. Our ﬁndings revealed a relatively high prevalence of microsporidia
species in immunodeﬁcient patients. The highest risk of this infection is at individuals with impaired immune
systems that it can be life-threatening in people with immune system dysfunction. It is essential that the high-risk
people should be receiving the information about the risk of direct contact with infected individuals and animals.
1. Introduction
Microsporidia are obligate intracellular pathogens. The parasite can
infect a wide range of vertebrate and invertebrate hosts among all over
the world (Mirjalali et al., 2015). Initially, the microorganisms assumed
as protozoa, but in the 1990s, according to phylogenetic and molecular
analysis, proofs showed relationship of these organisms and Fungi
(Pirestani et al., 2013). The phylum microsporidia is including about
150 genera and 1200 species. Encephalitozoon species (E. hellem, E.
intestinalis and E. cuniculi) and Enterocytozoon bieneusi (E. bieneusi) are
the most frequent causes of human infections (Sak et al., 2010).
Microsporidia are often considered as an opportunistic infection in
patients with impaired immune systems such as transplant recipients,
patients with acquired immune deﬁciency syndrome (AIDS), passen-
gers, children, elderly and people with ophthalmic lenses (Omalu et al.,
2006). In recent decades, several new species of microsporidia were
identiﬁed in AIDS patients that including E. bieneusi in 1985, E. hellem
in 1991 and Septata intestinalis in 1993 (Weber et al., 1994). The
microorganisms can be aﬀect all body organs and cause spectrum
symptoms such as myositis, keratoconjunctivitis, sinusitis, hepatitis and
disseminated infections (Omalu et al., 2006) and other clinical signs
consist of severe weight loss, chronic diarrhea, nausea and confusion
(Lindsay and Weiss, 2004). E. bieneusi and Encephalitozoon spp. have
been identiﬁed in animals that it is implying a zoonotic nature of these
microorganisms, but valid proofs for transmission from these animals to
human are lacking (Deplazes et al., 2000). Probably, many human
microsporidiosis have zoonotic origin and transferred by water con-
taminated with animal stool. However, human to human transmission
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has also been described (Samie et al., 2007).
Studies in Iran, on microsporidiosis in susceptible groups have been
performed recently, including prevalence studies in liver transplant
recipient patients (Agholi et al., 2013), animals (Jamshidi et al., 2012),
and HIV+/AIDS patients (Mirjalali et al., 2015) as well as with one
study reporting on the prevalence of E. bieneusi in pigeons (Pirestani
et al., 2013) but the current study is a novel research in southwest of
Iran. Opportunistic infections are one of the major factors in mortality
of patients with AIDS. Although, microsporidia are self-limited in
immunocompetent hosts, but these parasites can be life-threatening in
people with immune system dysfunction, especially in AIDS (Franzen
and Müller, 1999; Samie et al., 2007). For this reason, due to the
increasing prevalence of parasitic infections and immunodeﬁciency
diseases; the aim of the study is to evaluate molecular identiﬁcation of
Enterocytozoon bieneusi and Encephalitozoon spp. in immunodeﬁcient
patients in Ahvaz, southwest of Iran.
2. Methods
2.1. Study area
Ahvaz is a city in the center of Khuzestan province in Southwest of
Iran. The city is 375 square kilometers and its population has been
reported as 1,425,891 until 2006. The city has a desert climate with
temperatures above 50 °C that is one of the warmest cities in the world.
The average annual rainfall is about 230 mm. According to report by
the World Health Organization (WHO), Ahvaz has the most polluted
climate in the world (Saﬁ et al., 2016).
2.2. Sample collection
Initially, 310 stool samples were collected from immunodeﬁcient
patients referred to health centers and blood transfusion organization of
Khuzestan province, Southwest of Iran. At ﬁrst, the purpose and nature
of the study were told to the individuals. The next step, stool samples
were collected among them (Saﬁ et al., 2016). Subjects were screened
according to the inclusions and exclusions criteria. Inclusion criteria
were: non-smoker, no alcohol usage. Exclusion criteria were: history of
inﬂammatory diseases, diabetes, cardiovascular disease, thyroid, gas-
trointestinal, respiratory disorders, autoimmune diseases, and inﬂam-
matory status.
2.3. Ethical aspects
All experimental procedures were approved by the Ethics
Committee of Jundishapur University of Medical Sciences (with OG-
91109 code).
2.4. Preparing samples
The samples were collected and were transferred Department of
Parasitology, Ahvaz Jundishapur University of Medical Sciences. Then,
a part of the samples was used for smear preparation and staining. The
rest of the sample was mixed with twice the volume of potassium
dichromate 2.5% and were kept at 4 °C (Cama et al., 2007).
2.5. Samples examination by staining
All stool samples were stained by modiﬁed trichrome (weber). At
ﬁrst, the slides were ﬁxed with methanol. Then, the samples were
placed in trichrome color for 240 min. After decolorization with acid-
alcohol, and washing with 95% ethanol, the slides were placed in
absolute ethanol. At the next stage, to identify the spores, the slides
were examined by an optical microscope at magniﬁcation of x100
together with immersion oil. The positive samples were identiﬁed by
dorsal vacuoles in microsporidia spore (Pirestani et al., 2011a,b).
2.6. Extraction of DNA
The DNA was extracted by DNA extraction kits for stool (Bioneer)
and the extracted DNA was stored at −20 °C. This kit was consist of
spin column that the parasite DNA was absorbed by the column and
after twice washing with special buﬀers, the puriﬁed DNA was
obtained.
2.7. Molecular detection
The extracted DNA was examined by multiplex/nested PCR test that
the microsporidial genera of Enterocytozoon and Encephalitozoon were
identiﬁed by this method. At this stage, we used from speciﬁc primers
that were designed by Katzwinkel et al. (Katzwinkel-Wladarsch et al.,
1996). These primers were designed based on small subunit ribosomal
RNA (16S rRNA) gene that the primers were used for the identiﬁcation
of diﬀerent species of microsporidia. The primers were purchased from
Bioneer Company and were stored at −20 °C. Table 1 indicates the
primary and secondary primers used for multiplex/nested PCR. The
ampliﬁed fragment length by the primers was 500 bp and 300 bp for
the microsporidial genera of Enterocytozoon and Encephalitozoon, re-
spectively. At ﬁrst, the samples were examined with the primary and
secondary primers by Multiplex/nested PCR method. Then, for diﬀer-
entiating the species of Encephalitozoon, the products of Multiplex/
nested PCR were explored by RFLP method using the restriction enzyme
of Mnl1.
2.8. Sequencing
For genotyping, the positive samples of RFLP were sequenced by
Bioneer Company (Daejeon, South Korea). Afterwards, the speciﬁed
sequence was compared against the sequence of the registered isolates
available in the GenBank library (NCBI) and homology between them
was examined by BLAST software. Finally according to 54 nucleotide
sequences, the phylogenetic tree was drawn using the MEGA (version 7)
software and Neighbor-Joining method (Fig. 4).
2.9. Statistical analysis
SPSS statistical software of version 16 was used for the data analysis
and Chi-square test for signiﬁcance diﬀerences. The P-value less than
0.05 were considered signiﬁcant.
3. Results
3.1. Staining
Fig. 1 indicates microsporidia spore in the stool specimens of
immunodeﬁcient patients. Of 310, 93 samples were suspected positive
for microsporidia spore by the staining with modiﬁed trichrome
(weber) that 36, 34, 21, and 2 cases were observed in AIDS,
hematologic malignancy, hemodialysis and kidney transplant patients,
respectively. Of 93 positive samples of staining, 69 cases were observed
positive by the molecular detection with multiplex/nested PCR method.
Table 1
The primary and secondary primers used for multiplex/nested PCR (Katzwinkel-
Wladarsch et al., 1996).
The primary primers The secondary primers
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Also, other parasites were observed in the samples that including
Blastocystis hominis, Giardia lamblia, Entamoeba coli and Cryptosporidium
species.
3.2. Molecular identiﬁcation
Fig. 2 shows electrophoresis of the SSU rRNA gene PCR products on
Agarose gel 2% and Fig. 3 indicates electrophoresis of the RFLP
products on agarose gel 3%. Also, Table 2 shows the results of
molecular analysis and genotyping of the fecal samples of immunodeﬁ-
cient patients in Ahvaz, southwest of Iran. Based on the results, of 310,
88 samples were positive by the multiplex/nested-PCR test that of 88,
62 samples were positive for E. bieneusi. Also, 26 were detected as
Encephalitozoon species that including 3 E. cuniculi, 19 E. intestinalis and
4 E. hellem. Of 102 AIDS patients, 37 were positive that 23 patients had
CD4˂ 200 microliter and 13 patients had CD4˃200 microliter. The
results of other patients demonstrated in Table 2. No signiﬁcant
diﬀerences were found between the diﬀerent groups of patients with
immunodeﬁciency (AIDS, hemodialysis, hematologic malignancy and
tissue transplantation) and microsporidiosis (P > .05).
3.3. Sequencing and genotyping
According to Table 2, Of 62 positive samples of E. bieneusi, 45, 16
and 1 specimens were detected as genotype D, M and WL11, respec-
tively. Also, Of 3 positive specimens of E. cuniculi, 1 and 2 samples were
identiﬁed as genotype I and II, respectively. All E. hellem samples were
included genotype 1A. The data of nucleotide sequences reported in the
Fig. 1. Microsporidia spore in the stool sample that was stained by modiﬁed trichrome (weber), the slides were examined by optical microscope at magniﬁcation of x100.
Fig. 2. Electrophoresis of the SSU rRNA gene PCR products on agarose gel 2%, M: 100 bp molecular marker, sample 1: Encephalitozoon intestinalis positive control, sample 2: Negative
control, sample 3: Enterocitozoon bineusi positive control, samples 4–6: Positive samples for E.bineusi and samples7-9: Positive samples for E.intestinalis.
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paper are available in GenBank at accession numbers KY859460-
KY859513. Also, Fig. 4 shows phylogenetic analysis of ITS sequences
of microsporidia species isolates recovered from immunodeﬁcient
patients in Ahvaz, southwest of Iran.
4. Discussion
With improvement of molecular diagnostic methods, epidemiologi-
cal knowledge of microsporidia infections has been developed in
particular in the last decade (Pirestani et al., 2013). Reports related
to microsporidia infections in patients with chronic diarrhea are
increasing and its prevalence has reached 22% to 32% in developing
countries (Ignatius et al., 1997; Samie et al., 2007). Accordingly in this
study, we investigated microsporidiosis in immunodeﬁcient patients in
Ahvaz, southwest of Iran. Since, these microorganisms can be life-
threatening in immunodeﬁcient patients, especially in AIDS; these
patients were selected for the study. In this research, we used from
modiﬁed trichrome staining method based on the studies of Ryan et al.
(Ryan et al., 1993). In the staining, the background color of blue aniline
is stable and it has better contrast with other bacterial and fungal agents
(Ryan et al., 1993). On the other hand, the PCR technique is a successful
method that can be detect microsporidiosis with small numbers of
spores in the clinical and environmental samples. According to the
various studies, the detection threshold of microsporidia in fecal
samples is 100 and 10,000–1000,000 spores per gram of feces by PCR
and light microscopy, respectively. It represents the high sensitivity of
PCR in comparison with the staining methods (Garcia, 2002; Müller
et al., 2001).
Enterocytozoon bieneusi is the most common microsporidial species
isolated from people with immunodeﬁciency and even immunocompe-
tent individuals (Abdelmalek et al., 2011; Mirjalali et al., 2015). In the
current study, also, this microorganism had the highest prevalence in
immunodeﬁciency patients. Consistent with these results, in 2006,
Leelayoova et al. in Thailand indicated that the highest prevalence of
genotypes of E. bieneusi was related to genotype D (36.4%) in fecal
samples of AIDS patients. The phylogenetic analysis of the data
suggested the zoonotic importance of E. bieneusi (Leelayoova et al.,
2006). Also, genotype D has been suggested as the most common
genotype in most investigations (Thellier and Breton, 2008). So far,
only genotype D has been detected in transplantation patients, in Iran
(Agholi et al., 2013) but in our study, 1 case genotype M detected in the
transplantation patients of bone marrow. Our results besides other
investigations show that genotype D in almost immunodeﬁcient
patients could be associated with the widespread nature of the
genotype. Also, the number of transplantation individuals registered
in our research was lower than other groups such as AIDS, hemodialysis
and leukemia. Also, our ﬁndings show that of 62 positive samples of E.
bieneusi, 16 cases were detected as genotype M. Previous studies
showed that genotype M was only in animals (Pirestani et al.,
2011a,b) but in the study, we observed this genotype in immunodeﬁ-
cient patients that the results suggest the zoonotic potential of this
genotype.
On the other hand, our ﬁndings show that 26 cases were detected as
Encephalitozoon species that including 3 E. cuniculi, 19 E. intestinalis and
4 E. hellem. Encephalitozoon intestinalis is the second most common
microsporidial species infecting human (Deplazes et al., 2000) that this
is consistent with our results as well as in several studies, the parasite
besides E. hellem were detected in immunodeﬁcient patients (Deplazes
et al., 2000).The studies on E. cuniculi indicated that these microorgan-
isms were detected in 7 AIDS patients from Switzerland (Deplazes et al.,
1996; Weber et al., 1997), two cases from the USA (De Groote et al.,
1995; Mertens et al., 1997), and in one each from Germany (Franzen
et al., 1995), the United Kingdom (Hollister et al., 1995) and Italy
(Rossi et al., 1998), that prove the infection of E. cuniculi for
immunodeﬁcient patients. Also, immunodeﬁcient patients were de-
tected to be infected with the ‘dog strain’ in the Americas and with the
‘rabbit strain’ in Europe. In 1 AIDS patient from the UK, the E. cuniculi
‘dog strain’ was found (Hollister et al., 1996) that the results suggest the
zoonotic nature of these microorganisms.
Eventually, this study is important in terms of health; because the
opportunistic pathogens such as human microsporidiosis were isolated
Fig. 3. Electrophoresis of the RFLP products on agarose gel 3%, M: 100 bp molecular
marker, sample 1: Encephalitozoon spp. Positive control, sample 2: Negative control,
sample 3: Entrocitozoon bineusi positive control, sample 4: Encephalitozoon intestinalis (160
and 60 bp), sample 5: Encephalitozoon hellem (180 and 80 bp), sample 6: Encephalitozoon
cuniculli (210 and 90 bp).
Table 2
The results of molecular analysis and genotyping of the fecal samples of immunodeﬁcient patients in Ahvaz, southwest of Iran.
Patients Number E. bieneusi (Genotype) Encephalitozoon E. intestinalis E. cuniculi (Genotype) E. hellem (Genotype)
AIDS 102 21 (D)
8 (M)
8 6 1 (II) 1 (1A)
Leukemia 68 12 (D) 2 2 0 0
Lymphoma 12 1 (M) 0 0 0 0
Hodgkin lymphoma 20 5 (D)
3 (M)
1 0 0 1 (1A)
Hemodialysis 87 6 (D)
3 (M)
1 (WL11)
13 9 1 (I)
1 (II)
2 (1A)
Bone marrow transplant 12 1 (M) 2 2 0 0
Kidney transplant 8 1 (D) 0 0 0 0
Liver transplant 1 0 0 0 0 0
Total 310 62 26 19 3 4
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from patients with impaired immune systems in Ahvaz, southwest of
Iran. It has been reported that E. bieneusi and Encephalitozoon spp. have
been identiﬁed in animals (Deplazes et al., 2000) and birds (Yee et al.,
1991). Due to the zoonotic potential of the microsporidia as well as
because of the close relationship of these animals with humans, the
animals can be an important source of pollution. Therefore, in order to
the design of appropriate prevention programs for the parasite, it is
essential that the high-risk individuals such as patients with impaired
immune systems should be receiving the accurate information about the
risk of direct relationship with these animals. Also, it is recommended
to researchers to examine the diﬀerent hosts such as the domestic and
wild animals and the role of these animals in infecting high-risk
individuals and other people. Hence, it is need to examine the whole
range of epidemiological and molecular studies on the hosts. This study
is one of the rare studies that have investigated microsporidiosis in the
diﬀerent groups of patients with immunodeﬁciency (AIDS, hemodia-
lysis, hematologic malignancy and tissue transplantation) and the
current study is a novel research in southwest of Iran. Due to the
increasing prevalence of parasitic infections and immune deﬁciency
diseases such as patients with acquired immune deﬁciency syndrome
(AIDS), transplant recipients; the detection and species determination
of the parasites seems essential for the adoption of health strategies.
5. Conclusion
Our ﬁndings revealed a relatively high prevalence of microsporidia
species in immunodeﬁcient patients. The highest risk of this infection is
at individuals with impaired immune systems that it can be life-
threatening in people with immune system dysfunction. It is essential
that the high-risk people should be receiving the information about the
risk of direct contact with infected individuals and animals.
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